Cupid Limited has informed the Exchange regarding a press release dated October 18, 2025, titled "Cupid Limited Achieves CE (EU IVDR) Certification for Pregnancy and Syphilis Test Kits".
CUPID · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cupid Limited has received CE certification under the EU In Vitro Diagnostic Regulation (IVDR) for its pregnancy and syphilis rapid test kits. The certification was announced via a press release dated October 18, 2025. CE marking under IVDR is mandatory for in vitro diagnostic medical devices to be sold in the European Union. This milestone allows Cupid to legally market and distribute these diagnostic products across EU member states. Cupid is primarily known as a male contraceptive (condom) manufacturer, so this represents a move into the women's health and infectious disease diagnostics space.
Positive for shareholders — EU market access for two new diagnostic products opens a sizeable revenue opportunity and signals portfolio diversification beyond condoms. Stock may see short-term positive sentiment, though actual revenue impact depends on distribution deals and demand in Europe.